Isolation, characterization, anti-MRSA evaluation, and in-silico multi-target anti-microbial validations of actinomycin X2 and actinomycin D produced by novel Streptomyces smyrnaeus UKAQ_23Kamal A. Qureshi, Dinesh Kumar Prajapati, Abdul‐Hamid Emwas et al.|Scientific Reports|2021Cited by 69
In Vitro and In Silico Approaches for the Evaluation of Antimicrobial Activity, Time-Kill Kinetics, and Anti-Biofilm Potential of Thymoquinone (2-Methyl-5-propan-2-ylcyclohexa-2,5-diene-1,4-dione) against Selected Human PathogensKamal A. Qureshi, Muhammad Qaiser Fatmi, Mahrukh Imtiaz et al.|Antibiotics|2022Cited by 56
In Vitro and In Silico Approaches for the Antileishmanial Activity Evaluations of Actinomycins Isolated from Novel Streptomyces smyrnaeus Strain UKAQ_23Kamal A. Qureshi, Dinesh Kumar Prajapati, Gamal Osman Elhassan et al.|Antibiotics|2021Cited by 33